Start | End | Session | Location |
---|---|---|---|
08:30 | 10:00 | Saga Hall | |
Moderators: | John O’Shea, National Institutes of Health | ||
Ewa Sitnicka, Lund University | |||
08:30 | |||
Andreas Diefenbach, Charité Berlin | |||
Innate lymphoid cells and tissue remodeling | |||
08:50 | |||
Barbara Kee, University of Chicago | |||
ETS all about NK cells and innate lymphocytes | |||
09:10 | |||
Joseph Sun, Memorial Sloan Kettering Cancer Center | |||
Fasting reshapes tissue-specific NK cell immunity | |||
09:30 | |||
Sebastian Scheer, Luxembourg Institute of Health | |||
The methyltransferase DOT1L controls NK cell activation and lineage integrity. | |||
09:40 | |||
Stephanie Jost, Duke University | |||
Adaptive NK cells responses against antigenically distinct influenza viruses are partly mediated by HLA-E-stabilizing peptides derived from conserved antigens | |||
09:50 | |||
Everardo Hegewisch-Solloa, Columbia University Irving Medical Center | |||
A multifaceted deep dive into the NK cell developmental niche within human secondary lymphoid tissue. | |||
10:00 | 10:30 | Coffee Break | Foyer |
10:30 | 12:00 | Saga Hall | |
Moderators: | Michael Caligiuri, City of Hope National Medical Center | ||
Cynthia Dunbar, National Institutes of Health | |||
10:30 | |||
Nicolas Serafini, Institut Pasteur | |||
Intestinal ILC3: Better, Faster, Stronger | |||
10:50 | |||
Chiara Romagnani, Charité University and DRFZ Berlin | |||
Dynamics of human NK cell memory and clonality | |||
11:10 | |||
Yenan Bryceson, Karolinska Institutet | |||
To be announced | |||
11:30 | |||
Helena Arellano Ballestero, University College London | |||
Tumour-priming induces memory-like properties on NK cells: characterisation of the proteomic and receptor profile | |||
11:40 | |||
Ming Cheng, University of Science and Technology of China | |||
Transcription factor ROR-alpha promotes the formation and long-term maintenance of memory ILC1s | |||
11:50 | |||
Markus Uhrberg, Heinrich-Heine University Düsseldorf | |||
A novel human NK cell progenitor that originates in the thymus and generates NKG2A-KIR+ NK cells | |||
12:00 | 13:30 | Lunch | Restaurant |
13:30 | 15:00 | Saga Hall | |
Moderators: | Dimitra Peppa, University College London | ||
Quirin Hammer, Karolinska Institutet | |||
13:30 | |||
Mariapia Degli-Eposti, Monash University | |||
To be announced | |||
13:50 | |||
Catherine Blish, Stanford University | |||
Interrogating human coronavirus escape from and susceptibility to NK cell killing | |||
14:10 | |||
Stephen Waggoner, Cincinnati Children's Hospital Medical Center | |||
Using forensic victimology and immunological gun control to stop a follicular murder | |||
14:30 | |||
Simon Grassman, Memorial Sloan Kettering Cancer Center | |||
Early antigen-receptor signaling primes NK cells for optimal cytokine signaling during infection | |||
14:40 | |||
Jesse Bruijnesteijn, Biomedical Primate Research Centre | |||
Chromosomal rearrangements in the KIR gene cluster as evolutionary strategy to fight fast evolving pathogens | |||
14:50 | |||
Wilfredo Garcia-Beltran, Ragon Institute of Mass General, MIT and Harvard | |||
SARS-CoV-2 evades NK-cell immunity by ORF6-mediated shedding of NKG2D ligands, uncovering a novel immunotherapeutic target conserved among sarbecoviruses | |||
15:00 | 15:30 | Coffee Break | Foyer |
15:30 | 16:40 | Saga Hall | |
Moderators: | Marcus Altfeld, Leibniz Institute for Virology | ||
Clair Gardiner, Trinity College Dublin | |||
15:30 | |||
Mary Carrington, Frederick National Laboratory for Cancer Research | |||
Impact of HLA class I Signal Peptide Variation on HLA-E interactions with CD94/NKG2A | |||
15:50 | |||
Marit Inngjerdingen, University of Oslo | |||
Unravelling the heterogeneity of extracellular vesicles released from NK cells | |||
16:10 | |||
Patrick Ross, San Diego Biomedical Research Institute | |||
Leveraging MINFLUX Nanoscopy to Understand NK Cell Immunological Synapse Structure and Dynamics | |||
16:20 | |||
Anzelika Rubina, Cardiff University | |||
Human cytomegalovirus genes UL148 and UL148D inhibit NK cell function by promoting surface expression of inhibitory ligands via impairment of ADAM17 | |||
16:30 | |||
Jean De Lima , University of Basel | |||
Redefining the lung immune cell network: crosstalkbetween HIF-1a+ CD4 T cells and NK cells during influenza infection | |||
16:40 | 17:10 | Saga Hall | |
Moderators: | Amir Horowitz, Mount Sinai | ||
Janine Melsen, Leiden University Medical Center | |||
16:40 | |||
Giovanna Perinetti Casoni, Karolinska Institutet | |||
DEF6 promotes canonical CD56dim NK cell survival and cytotoxicity | |||
16:45 | |||
Adriana Mujal, Memorial Sloan Kettering Cancer Center | |||
Tissue-specific determinants of adaptive NK cell responses | |||
16:50 | |||
Tomas Hofman, Heidelberg University | |||
IFNg- and sialic acid pathways drive melanoma resistance via selective inhibition of NK cell subsets. | |||
16:55 | |||
Nicole Wild, Karolinska Institutet | |||
Characterisation of organ-specific tissue-resident NK cells across human tissues | |||
17:00 | |||
Janine Melsen, Leiden University Medical Center | |||
Deciphering human NK cell development using high-dimensional phenotyping and imaging: tonsil versus thymus | |||
17:05 | |||
Roseanna Hare, University of Manchester | |||
Ligand mobility is necessary for TIGIT to assemble into nanoscale clusters at immune synapses | |||
17:30 | 20:00 | Visit to Fram museum [Ticket Required] | Fram |
20:00 | 21:30 | Poster Sesson 2, B001-B131 | Poster Area |